5 results  1 of 1 

1 High Serum Levels of Thyroid-Stimulating Hormone and Sustained Weight Gain in Patients with Thyroid Cancer Undergoing Radioiodine Therapy
Hyo Jung Seo, June-Key Chung, Keon Wook Kang, E. Edmund Kim, Gi Jeong Cheon, Jin Chul Paeng, Dong Soo Lee, Young Joo Park, Do Joon Park, Jae Gol Choe
Int J Thyroidol.2016;9(1):19-28.   Published online 2016 May 20     DOI: http://dx.doi.org/10.11106/ijt.2016.9.1.19
   
2 Radioiodine Therapy in Differentiated Thyroid Cancer: The First Targeted Therapy in Oncology
June-Key Chung, Gi Jeong Cheon
Endocrinol Metab.2014;29(3):233-239.   Published online 2014 September 25     DOI: http://dx.doi.org/10.3803/EnM.2014.29.3.233
   
3 Radioiodine Therapy: Review of the Empiric Fixed Dose Approaches and Their Selective Applications
Mi Park Jung
J Korean Thyroid Assoc.2013;6(1):34-42.   Published online 2013 May 3     DOI: http://dx.doi.org/10.11106/jkta.2013.6.1.34
   
4 Fifteen Years or Greater Follow-Up of Pediatric Differentiated Thyroid Cancer
A Ram Kim M.D., Chi Won Sung M.D., Young Sam Park M.D., Cheol Seung Kim M.D., Kab Tae kim M.D.
Korean J Endocr Surg.2010;10(1):34-38.   Published online 2010 March 18     DOI: http://dx.doi.org/10.16956/kjes.2010.10.1.34
   
5 Verification of Measurement Methods and Therapeutic Efficacy of Maximum Permissible Dose of I-131 in High Risk Patients with Differentiated Papillary Thyroid Cancer
Jung Chul Kim, Jung Han Yoon, Young Jong Jaegal, Hee Seung Bum
Korean J Endocr Surg.2002;2(2):97-104.   Published online 2002 December 31     DOI: http://dx.doi.org/10.16956/kjes.2002.2.2.97
      

 1 of 1